Diabetes, specifically type II, has become a major health concern for our society in the past few decades. We have reached epidemic standards with the amount of diabetic patients we are now seeing. Around 30.3 million Americans, roughly 9.4% of the population, had diabetes in 2015 according to the American Diabetes Association. Type II diabetes used to only be seen in our older populations, however, now we are seeing an increases in our youth being diagnosed with diabetes; around 193,000 Americans under the age of the 20 have diabetes.
Why should we be concerned by the rising prevalence of diabetes? Diabetes is no minor disorder; it comes with serious health complications. Some including:
- Skin complications: acanthosis nigricans, diabetic dermopathy and diabetic blisters
- Eye complications: glaucoma and cataracts
- Neuropathy: nerve damage
Diabetes is also closely associated with cardiovascular disease, which can lead to heart attack, stroke and even death.
How can Diabetes be Treated?
The problem with type II diabetes is the body not being responsive enough to the hormone insulin, which is responsible for getting glucose from your blood into your cells. This leads to having high “blood glucose levels.” Having this excess sugar in your blood can lead to these aforementioned health problems. Diabetes medications work by keeping these blood glucose levels within a healthy range. Another method of monitoring your blood sugar levels is to track your A1c levels, which measure HbA1c, a type of protein that bind to glucose in your blood. Normal HbA1c levels are less than 5.7%, and diabetics usually have HbA1c levels above 6.5%.
Metformin is a common medication that is prescribed to diabetics. Though its exact mechanism is not known, it is thought to work on the insulin receptors rather than on the pancreas, the organ that produces insulin. There are many other medications that may be used in conjunction with Metformin depending on the severity of a patient’s insulin sensitivity.
Our Research
The goals of our research are:
- To see if HbA1c levels can be lowered to healthy ranges while a patient is only using Metformin
We want to use HbA1c tests to track a patient’s progress as it tells us the average blood sugar levels over the past two to three months and it will be more indicative of how a patient is healing in general. We chose to use only Metformin as we want to find out if Metformin is capable of lowering HbA1c levels to healthy ranges without any other treatments
- To see if a patient’s lifestyle responds well to using Metformin as their sole diabetes medications as opposed to taking multiple medications daily
We want to see how patients respond to only using one medication as opposed to multiple medications in terms of lifestyle. Lifestyle is a major component in managing diabetes, and simplifying a routine to taking one medication would be the easiest way to manage this disorder.
- To see if there are any side effects associated with using Metformin
There are certain side effects that we want to avoid when treating diabetes, such as weight gain, which can only make things worse.
How are we going to carry out our research?
We plan on holding a clinical trial using sixteen participants who meet out eligibility criteria based on age and medical history. Eight participants will be given Metformin to take daily, and the other eight participants will be given a placebo pill to take daily. All participants will be under the supervision of a licensed physician and will take monthly blood tests to monitor their HbA1c levels. Those individuals taking Metformin will be given a survey after the trial has ended to see how Metformin fits with their lifestyle.

Why is this Important?
23.1 Million Americans have diabetes and do not know it and are not receiving the proper treatments. We hope that our research will help diabetes advocacy and people will be more aware of their health and can see out proper treatments without fear that their life will change drastically.

References
1. Statistics about Diabetes. 2018 Mar 22. American Diabetes Association; [accessed 2019 Jan 31]. http://www.diabetes.org/diabetes-basics/statistics/
2. Tabish SA, Is Diabetes Becoming the Biggest Epidemic of the Twenty-first Century?, International Journal of Health Sciences (Qassim). 2007: 1(2): V-VIII.
3. Mahrooz A, Parsanasab H, Hashemi-Soteh MB, Kashi Z, Bahar A, Alizadeh A, Mozayeni M, The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study, Clinical and Experimental Medicine. 2015:15(2):159-165.
4. TODAY Study Group, Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY, Diabetes Care. 2013:36:1749-1757.
5. Yanovski JA, Krakoff J, Salaita CG, McDuffie JR, Kozlosky M, et al., Effects of Metformin on Body Weight and Body Composition in Obese Insulin-Resistant Children: A Randomized Clinical Trial, Diabetes. 2011:60(2):477-485.
6. Harborne L, Fleming R, Lyall H, Normal J, Sattar N, Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome, The Lancet. 2003: 361(9372): 1894-1901.
7. Florez H, Luo J, Castillo-Florez S, Mitsi G, Hanna J, Tamariz L, et al., Impact of Metformin-Induced Gastrointestinal Symptoms of Life and Adherence in patients with Type 2 Diabetes. 2015:122(2):112-120.
